The adenosine A1 receptor (ADORA1), which functions as a receptor for adenosine, has been documented to exhibit pro-tumor growth effects in breast carcinoma, renal cancer, and hepatocellular carcinoma (7–9). Here, ADORA1 is linked to renal carcinoma.